Pharmacokinetics and safety of fibrinogen concentrate
Open Access
- 23 November 2009
- journal article
- research article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 7 (12) , 2064-2069
- https://doi.org/10.1111/j.1538-7836.2009.03633.x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Rotational thromboelastography for monitoring of fibrinogen concentrate therapy in fibrinogen deficiencyBlood Coagulation & Fibrinolysis, 2008
- Pharmacokinetics and pharmacodynamics of a new highly secured fibrinogen concentrateJournal of Thrombosis and Haemostasis, 2008
- Reply. Pereira A. Cryoprecipitate versus commercial fibrinogen concentrate in patients who occasionally require a therapeutic supply of fibrinogen: risk comparison in the case of an emerging transfusion-transmitted infection.Haematologica, 2008
- Incidence of bleeding symptoms in 100 patients with inherited afibrinogenemia or hypofibrinogenemiaJournal of Thrombosis and Haemostasis, 2006
- Multi-centre investigation on reference ranges for ROTEM thromboelastometryBlood Coagulation & Fibrinolysis, 2005
- Pharmacokinetic properties of a pasteurised fibrinogen concentrateTransfusion and Apheresis Science, 2005
- Efficacy and tolerability of a pasteurised human fibrinogen concentrate in patients with congenital fibrinogen deficiencyTransfusion and Apheresis Science, 2005
- Spontaneous intracranial bleeding in two patients with congenital afibrinogenaemia and the role of replacement therapyHaemophilia, 2000